Bortezomib will improve the amount or result of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Greater flibanserin adverse outcomes may possibly happen if coadministered with various weak CYP3A4 inhibitors. elvitegravir/cobicistat/emtricitabine/tenofovir DF will increase amounts of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 m... https://theodoreh655vgr8.hamachiwiki.com/user